STOCK TITAN

DYNATRONICS CORP - DYNT STOCK NEWS

Welcome to our dedicated page for DYNATRONICS news (Ticker: DYNT), a resource for investors and traders seeking the latest updates and insights on DYNATRONICS stock.

Dynatronics Corp (NASDAQ: DYNT) is a prominent United States-based company renowned for its innovative medical devices and restorative products targeted towards achieving optimal health. Established over 31 years ago, Dynatronics has built a robust reputation for competitive pricing, exemplary customer service, and unmatched clinical support. The company designs, manufactures, and distributes advanced-technology medical devices, therapeutic tables, rehabilitation equipment, and a wide array of rehabilitation and therapy products and supplies.

Dynatronics’ product portfolio includes electrotherapy, therapeutic ultrasound, phototherapy, customized athletic training treatment tables, institutional cabinetry, and exercise products. These products are marketed to a diverse range of healthcare professionals such as physical therapists, chiropractors, athletic trainers, and sports medicine practitioners. The company’s commitment to quality is reflected in its reputable brands including Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™, among others.

With over 60 sales representatives and 150 active distributors located nationwide, Dynatronics ensures immediate service and extensive field support, from equipment setup to in-service training. Their experienced and knowledgeable sales force is one of the most respected in the industry.

In recent developments, Dynatronics has made significant strides to optimize its cost structure and strengthen its balance sheet. The company recently entered into a new Loan and Security Agreement with Gibraltar Business Capital, enhancing its operational and financial flexibility. Additionally, Brian Baker has assumed the role of Chief Executive Officer, bringing a wealth of experience and a customer-focused approach to the leadership team.

The company has shown resilience and adaptability amidst economic challenges, continuously working on business optimization strategies. The financial guidance for fiscal year 2024 shows a net sales target of $34 million to $37 million, with a strategic focus on cost reduction and margin expansion.

Dynatronics is also focusing on launching new products, with plans for a limited launch in the third quarter and a full launch in the fourth quarter of fiscal year 2024. These new product lines are expected to complement their existing offerings and contribute to the company's revenue growth.

For more information about Dynatronics Corp and its latest updates, visit www.dynatronics.com.

Rhea-AI Summary

Dynatronics (NASDAQ: DYNT) announced its transition to the OTC Markets Group due to noncompliance with Nasdaq's minimum bid price requirement. The company received notice of impending delisting from Nasdaq effective July 9, 2024. Consequently, Dynatronics' common stock will be quoted on the OTCQB Venture Market immediately following the delisting. The ticker symbol and CUSIP will remain unchanged, and shareholders need not take any action. Despite the transition, Dynatronics will continue its business operations and remain a reporting company under the Securities Exchange Act of 1934.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.97%
Tags
none
-
Rhea-AI Summary

Dynatronics , a leading manufacturer of athletic training, physical therapy, and rehabilitation products, reported financial results for its third quarter of fiscal year 2024. The CEO highlighted progress in sales goals and positive EBITDA. New product lines were introduced to enhance sales. Key financial results include total net sales of $7.7 million, a gross profit margin of 23.7%, and a net loss attributable to common stockholders of $0.9 million. The company provided guidance for fiscal year 2024, estimating net revenue to be $32.5 million to $34 million, with ongoing volatility expected due to economic challenges. Dynatronics will hold a conference call to review its third quarter results.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.32%
Tags
-
Rhea-AI Summary
Dynatronics announced its plan to release financial results for the third quarter of fiscal year 2024 on May 9, 2024. The company will also conduct a conference call with analysts to discuss the results.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.44%
Tags
conferences earnings
Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) reported financial results for its second quarter of fiscal year 2024, showing progress towards sales goals and positive EBITDA. The company plans to launch new products in the third and fourth quarters of fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-29.85%
Tags
-
Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) will release its financial results for the second quarter of fiscal year 2024 on February 8, 2024. The company will also hold a conference call with analysts to review the results. Interested persons can access the live conference call by dialing 1-800-319-4610 (U.S./Canada callers) or +1-604-638-5340 (international callers). An audio replay will be available until February 15, 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.32%
Tags
conferences earnings
-
Rhea-AI Summary
Dynatronics Corporation (NASDAQ: DYNT) announced the appointment of Andrew Hulett to its Board of Directors, filling the vacancy created by Scott Klosterman's resignation. Hulett brings extensive experience in business development, particularly in HR outsourcing services, and has successfully led the sale of businesses in the past. His appointment is expected to provide additional resources for the company's business strategies and growth opportunities.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
management
Rhea-AI Summary
Leixir Dental Laboratory Group (Leixir) (NASDAQ: LDXR) appoints John Krier as Chief Executive Officer, effective January 2nd, 2024. Mr. Krier brings nearly two decades of executive leadership experience in the medical device manufacturing and distribution industries, succeeding founder Harmeet Bindra who continues as Executive Chairman. The appointment aims to drive operational excellence and expand Leixir's customer base, DSO relationships, and service offerings to support best-in-class dental patient care.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.28%
Tags
management
-
Rhea-AI Summary
DYNT: Dynatronics Corporation Reports Q1 Fiscal Year '24 Financial Results, Reaffirms Guidance, and Announces Conference Call
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.99%
Tags
-
Rhea-AI Summary
Dynatronics Corporation appoints Gabe Ellwein as Chief Financial Officer, effective October 30, 2023. Ellwein will lead the company's finance, accounting, and investor relations teams. He brings extensive experience in finance, manufacturing, supply chain, and product leadership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.13%
Tags
management
Rhea-AI Summary
Dynatronics Corporation to release financial results for its fiscal year first quarter on November 9, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.09%
Tags
conferences earnings

FAQ

What is the current stock price of DYNATRONICS (DYNT)?

The current stock price of DYNATRONICS (DYNT) is $0.1325 as of December 24, 2024.

What is the market cap of DYNATRONICS (DYNT)?

The market cap of DYNATRONICS (DYNT) is approximately 1.0M.

What does Dynatronics Corp specialize in?

Dynatronics Corp specializes in designing, manufacturing, and distributing advanced-technology medical devices, therapeutic and medical treatment tables, and rehabilitation equipment.

Who are the primary customers of Dynatronics?

Dynatronics markets its products to physical therapists, chiropractors, athletic trainers, sports medicine practitioners, and other medical professionals and institutions.

What recent financial steps has Dynatronics taken?

Dynatronics entered into a new Loan and Security Agreement with Gibraltar Business Capital to enhance operational and financial flexibility.

What are some of Dynatronics' well-known brands?

Some of Dynatronics’ well-known industry brands include Bird & Cronin®, Solaris™, Hausmann®, Physician's Choice®, and PROTEAM™.

What are the company's recent achievements?

Recent achievements include the optimization of the company’s cost structure, strengthening its balance sheet, and the appointment of Brian Baker as CEO.

What are Dynatronics' financial goals for fiscal year 2024?

The financial goals for fiscal year 2024 include net sales of $34 million to $37 million, focusing on cost reduction and margin expansion.

How does Dynatronics support its customers?

Dynatronics supports customers through a knowledgeable sales force, competitive pricing, excellent customer service, and field support from equipment setup to in-service training.

What new product launches are expected from Dynatronics?

Dynatronics plans a limited launch of new products in the third quarter and a full launch in the fourth quarter of fiscal year 2024, aiming to complement their existing products and drive revenue growth.

How long has Dynatronics been in business?

Dynatronics has been in business for over 31 years, establishing a solid reputation in the industry.

Where can I find more information about Dynatronics?

More information about Dynatronics can be found on their official website at www.dynatronics.com.

DYNATRONICS CORP

Nasdaq:DYNT

DYNT Rankings

DYNT Stock Data

1.01M
4.11M
43.29%
0.3%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States of America
SALT LAKE CITY